We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.8M
AUM Growth
+$681K
Cap. Flow
-$442M
Cap. Flow %
-1,939.41%
Top 10 Hldgs %
14.43%
Holding
3,409
New
162
Increased
850
Reduced
1,040
Closed
145

Top Buys

Rank Stock Value
1
EA icon
Electronic Arts
EA
+$114M
2
CDNS icon
Cadence Design Systems
CDNS
+$112M
3
FTNT icon
Fortinet
FTNT
+$81.7M
4
CMI icon
Cummins
CMI
+$68.3M
5
XLNX
Xilinx Inc
XLNX
+$58.6M

Sector Composition

Rank Sector Weight
1 Technology 15.74%
2 Healthcare 13%
3 Financials 12.4%
4 Industrials 10.58%
5 Consumer Discretionary 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHAS
1301
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$65 ﹤0.01%
+5,000
New +$61.3K
GS.PRJ
1302
DELISTED
GOLDMAN SACHS GROUP, INC. 5.50% SER J
GS.PRJ
$65 ﹤0.01%
2,511
AMCR icon
1303
Amcor
AMCR
$20.9B
$64 ﹤0.01%
+1,118
New +$62K
EXEL icon
1304
Exelixis
EXEL
$14B
$64 ﹤0.01%
3,022
MGPI icon
1305
MGP Ingredients
MGPI
$384M
$64 ﹤0.01%
969
+110
+13% +$7.75K
RES icon
1306
RPC Inc
RES
$1.21B
$64 ﹤0.01%
9,000
RH icon
1307
RH
RH
$3.4B
$64 ﹤0.01%
558
WPM icon
1308
Wheaton Precious Metals
WPM
$50.9B
$64 ﹤0.01%
2,647
+229
+9% +$5.08K
TMX
1309
DELISTED
Terminix Global Holdings, Inc.
TMX
$64 ﹤0.01%
1,243
-51
-4% -$2.62K
PS
1310
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$64 ﹤0.01%
+2,140
New +$68.7K
KYN.PRF.CL
1311
DELISTED
Kayne Anderson MLP/Midstream Investment Company 3.500% Series F Mandatory Redeemable Preferred Share
KYN.PRF.CL
$64 ﹤0.01%
2,561
APTV icon
1312
Aptiv
APTV
$12.2B
$63 ﹤0.01%
796
+16
+2% +$1.27K
VISN
1313
Vistance Networks Inc
VISN
$2.67B
$63 ﹤0.01%
4,059
+956
+31% +$19.4K
SANM icon
1314
Sanmina
SANM
$11.2B
$63 ﹤0.01%
2,117
WFC.PRR
1315
DELISTED
WELLS FARGO & COMPANY Depositary Shares, each representing a 1/1,000th interest in a share of 6.625% Fixed-to-Floating Rate Non-Cumulative Perpetual Class A Preferred Stock, Series R
WFC.PRR
$63 ﹤0.01%
2,250
LFC
1316
DELISTED
China Life Insurance Company Ltd.
LFC
$63 ﹤0.01%
5,114
KNBWY
1317
DELISTED
KIRIN BREWERY LTD SPONSORED ADR
KNBWY
$63 ﹤0.01%
2,934
-422
-13% -$9
CRL icon
1318
Charles River Laboratories
CRL
$10.8B
$62 ﹤0.01%
439
-180
-29% -$24.4K
IPGP icon
1319
IPG Photonics
IPGP
$3.81B
$62 ﹤0.01%
405
-235
-37% -$35.5K
FRE.PRZ
1320
DELISTED
FREDDIE MAC FIXED FLG RT NON CUM PERP PREF
FRE.PRZ
$62 ﹤0.01%
+5,000
New +$62
AEO icon
1321
American Eagle Outfitters
AEO
$2.98B
$61 ﹤0.01%
3,646
-37,100
-91% -$751K
FCPT icon
1322
Four Corners Property Trust
FCPT
$2.83B
$61 ﹤0.01%
2,258
+163
+8% +$4.66K
IMO icon
1323
Imperial Oil
IMO
$60.8B
$61 ﹤0.01%
2,233
+1,618
+263% +$45.4K
LEN icon
1324
Lennar Class A
LEN
$20.5B
$61 ﹤0.01%
1,317
-284
-18% -$14.2K
FFTY icon
1325
CapForce IBD 50 ETF
FFTY
$79.9M
$60 ﹤0.01%
1,772

Similar funds

Glenmede Trust's Q2 2019 Portfolio in Review

As of Q2 2019, Glenmede Trust held 3,409 positions worth $22.8M, up 3.1% from $22.1M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust withdrew a net $442M in Q2 2019, closing 145 positions and reducing 1,040 holdings. Its most notable exit was Sinclair Inc, an estimated $23.5K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Dow Inc worth $29.7K.

  • Glenmede Trust's largest Q2 2019 buy was Dow Inc: 602,067 shares worth $29.7K.
  • Glenmede Trust added most to Electronic Arts in Q2 2019, an estimated $114M increase.
  • Glenmede Trust's biggest Q2 2019 reduction was Cognizant, cutting an estimated $93.3M.
  • Glenmede Trust fully exited Sinclair Inc in Q2 2019, selling an estimated $23.5K.
  • Glenmede Trust's ten largest holdings make up 14% of its $22.8M portfolio in Q2 2019.
  • Glenmede Trust opened 162 new positions and closed 145 in Q2 2019.
  • Glenmede Trust's portfolio value rose 3.1% quarter-over-quarter to $22.8M.

Based on Glenmede Trust's 13F filing for Q2 2019, filed 13 Aug 2019.